A Closer MRI Look May Help Clarify Your MS Diagnosis
By MS Buddy ·
Summarized from European radiology, Oct 2026 · PubMed · DOI. AI-generated summary. Not medical advice.
Research by Marco Parillo, Àlex Rovira and 4 colleagues at University Medicine Halle, Azienda Sanitaria Universitaria Integrata del Trentino and 2 other institutions in Germany, Italy, the United Kingdom and 1 other country.
Key Takeaway
A special type of MRI may help doctors tell whether spots in the brain are linked to MS, but the images need careful review.
What They Found
This article gives expert recommendations on a type of MRI scan that is especially good at showing small veins and iron in the brain. For MS, it may help doctors look for a tiny vein running through the center of a brain spot. It may also show a dark rim around some spots, which can be a clue about ongoing inflammation, or swelling, there. The experts recommend using this scan during an MS evaluation when these clues could help answer a clinical question. They also say doctors should check several versions of the images because the scan can create misleading effects, much like a shadow can make an object look larger than it is.
Who Should Care and Why
If you are being evaluated for MS, this scan may give your care team more information about spots seen on a standard MRI. If you already have MS, your doctor may consider it when a closer look at those spots would help with your care. Caregivers may find it useful to know that one MRI can provide different kinds of images, each showing part of the picture. You can ask your doctor whether this scan would answer a specific question about your MRI results. The main practical point is not to request an extra scan for everyone, but to talk through what your images show and what remains unclear.
Important Considerations
This article offers imaging recommendations; it does not show that the scan improves symptoms or treatment results. The MS-related clues are useful only in certain situations and cannot diagnose MS on their own. Image effects and differences between MRI machines can change how findings look, so careful review matters.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in European radiology by et al.. Reproduced from the PubMed record.
Susceptibility-weighted imaging (SWI) is a high-resolution 3D gradient-echo (GRE) magnetic resonance imaging (MRI) technique that combines magnitude and phase information to increase sensitivity to blood products, iron, calcification, thrombus, and venous structures. In routine practice, SWI should be interpreted together with source magnitude images, filtered phase images, processed SWI images, and minimum-intensity projection (minIP) images, keeping in mind blooming and other artefacts, as well as vendor-dependent phase conventions. Its most established role is in brain MRI, particularly in: suspected cerebral amyloid angiopathy; baseline and follow-up assessment of amyloid-related imaging abnormalities with haemosiderin deposition (ARIA-H) during anti-amyloid therapy; traumatic brain injury; multiple sclerosis work-up, when assessment of the central vein sign or paramagnetic rim lesions is clinically relevant; neuro-oncology; and vascular malformations. Overall, these constitute the core recommended brain scenarios for SWI supported by moderate to high levels of evidence. Outside neuroradiology (e.g., musculoskeletal, abdominal, breast, pelvic, and cardiac imaging), SWI remains promising but less standardised and should currently be reserved for selected problem-solving indications. KEY POINTS: SWI should be acquired as a high-resolution 3D GRE sequence and interpreted together with source magnitude images, filtered phase images, and post-processed minIP images, keeping in mind blooming and other artefacts, as well as vendor-specific phase conventions. SWI should be included in brain MRI protocols when haemorrhagic or microvascular susceptibility findings are expected to affect diagnosis or management, especially in cerebral amyloid angiopathy, anti-amyloid therapy monitoring, traumatic brain injury, and neuro-oncology or multiple sclerosis work-up. Outside neuroradiology, SWI can be used as a targeted problem-solving adjunct rather than as a routine sequence.
Explore more research
Check out the MS Buddy app
It’s free, with no ads. Built by people living with MS.
Related MS research
11/8/2026
A study finds a short survey may help spot worry about the unknown in people with MS. Learn what it
Read More
11/6/2026
A study of children with MS linked higher propionate, a substance made in the gut, with less disease
Read More
11/4/2026
Could a short voice recording help track MS changes? Learn why speech-checking tools show promise fo
Read More
11/3/2026
A study of two MS medicines found MRI scans may help confirm relapses and clarify treatment differen
Read More
11/3/2026
A large MS records study found fewer Alzheimer’s diagnoses among people given natalizumab. Learn wha
Read More
11/3/2026
MS symptoms can worsen even without relapses. Learn why walking tests may miss changes, and how trac
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.